Financials

News Ideas Discussions Technicals Forecast Seasonals

FLERIE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Flerie AB engages in the development of drugs for the treatment of diseases such as inflammation and cancer. It conducts research, technology development, and commercialization of scientific discoveries in the biomedical field. The company was founded by Oliver von Stein and Svante Rasmuson in 2000 and is headquartered in Stockholm, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

FLERIE has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company